Capsaicin-sensitive afferents and blood pressure regulation during pentobarbital anaesthesia in the rat.
(1) Maintenance of blood pressure was investigated during induction of pentobarbital anaesthesia in rats after elimination of capsaicin-sensitive afferent neurons (capsaicin-denervated rats) as compared to vehicle-treated controls. The catecholamine content of heart and adrenals and the rise in blood pressure following electrical excitation of the spinal adrenergic nerves (pithed rat preparation) was also compared between both groups. (2) Capsaicin-denervated rats and their controls had equal amounts of catecholamines in heart and adrenals as well as equal pressor responses to electrical stimulation of spinal sympathetic nerves, thus excluding an influence of capsaicin on efferent pathways. In the state of consciousness, both groups showed the same blood pressure. (3) In capsaicin-denervated rats and in their controls, pentobarbital-induced anaesthesia (50 mg/kg i.p.) was characterized by a decline in blood pressure during the first 6 min. In the controls, this fall in blood pressure was followed by a slow compensatory rise to a level slightly higher than before anaesthesia, and this level was maintained during the following 60 min. This compensation was completely absent in capsaicin-denervated rats, indicating a role for capsaicin-sensitive nerves in this mechanism. An injection of pentobarbital (50 mg/kg i.p.) in pithed rats reduced the pressor response to electrical stimulation of spinal sympathetic nerves by about 40% in capsaicindenervated rats and in their controls. This inhibitory effect of pentobarbital might be involved in the initial fall in blood pressure in intact animals.(ABSTRACT TRUNCATED AT 250 WORDS)
Bramhall
T
T
Institut für Experimentelle und Klinische Pharmakologie, Universität Graz, Austria.
Decrinis
M
M
Donnerer
J
J
Lembeck
F
F
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000758:Anesthesia; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002211:Capsaicin / Q000494:pharmacology*; D002216:Captopril / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009121:Muscle Denervation; D009206:Myocardium / Q000378:metabolism; D009475:Neurons, Afferent / Q000187:drug effects*; D009599:Nitroprusside / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats
D002395:Catecholamines; D009599:Nitroprusside; D002216:Captopril; D010424:Pentobarbital; D002211:Capsaicin; D010646:Phentolamine